The recent study details the use of fat-referenced volumetric muscle composition measurements as reliable biomarkers of disease progression and treatment response in sporadic inclusion body myositis, building upon AMRA’s increasing expertise in the neuromuscular disease space
Medical Research
AMRA® Profiler 4 Pilot Study Demonstrates Feasible Assessment of Muscle Composition in Liver Transplant Candidates
The newly MDR-certified (NB 2862), next-generation AMRA® Profiler 4 device, a unique approach for quantifying fat and muscles, was evaluated in the study to be helpful in liver disease research, representing a crucial step forward for the use of muscle composition assessments in the field
New AMRA Medical Study Published in Obesity Links Antidepressant Use with Poor Muscle Health and Increased Cardiometabolic Risk
The recent study – part of the CoMorMent initiative – provides new evidence for body composition measurements as an important tool for examining adverse treatment effects associated with the use of antidepressants
Adapting To Change: New Focused Review in Circulation Explores The Relationship Between Weight Reduction and Muscle Health
The recently published primer summarizes contemporary evidence indicating that muscle composition changes associated with GLP-1-based therapies appear to be adaptive
AMRA Medical To Highlight the Importance of Maintaining Muscle Health in Type II Diabetes at Annual EASD Meeting
Researchers from AMRA will present an abstract at the 60th annual European Association for the Study of Diabetes Meeting that emphasizes the link between adverse muscle composition and all-cause mortality in Type II Diabetes
Recent AMRA Medical Findings Presented at the 2024 ERA Congress Link Adverse Muscle Composition to Mortality in CKD
AMRA expands footprint in kidney disease research with updated results from a study exploring various biomarkers’ potential in characterizing muscle composition’s role in chronic kidney disease progression and identifying at-risk patients